Clinical Trials Logo

Clinical Trial Summary

Coronavirus disease 2019 (COVID-19) is a highly infectious pandemic disease caused by SARS-CoV-2 virus. Central Nervous System (CNS) complications associated with COVID-19 might be secondary sequelae due to exuberant systemic innate-mediated hyper-inflammation, which may impair neurovascular endothelial function, disrupt blood brain barrier (BBB), activates CNS innate immune signaling pathways, and induces parainfectious autoimmunity, potentially contributing to the CNS manifestations. Although the predominant clinical manifestation of SARS-CoV-2 is characterized by dyspnea, unremitting fever and hypoxemic respiratory failure, neurologic manifestations do occur in most hospitalized SARS-CoV-2 patients and include non-specific encephalopathy, psychosis, meningitis/encephalitis, myelitis, cerebrovascular events, Guillain-Barre' syndrome, and cranial or peripheral neuropathies, such as anosmia and ageusia. To date, data about primary CNS involvement due to neurotropism and direct neuroinvasion are still lacking.


Clinical Trial Description

Determination of SARS-CoV-2 presence in central nervous system ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04775784
Study type Observational
Source IRCCS San Raffaele
Contact Laura Sincinelli
Phone 00390226435568
Email sincinelli.laura@hsr.it
Status Recruiting
Phase
Start date December 17, 2020
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05473936 - A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination N/A
Enrolling by invitation NCT05178290 - Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers N/A
Completed NCT04926779 - Study Utilizing BIOZEK COVID-19 Antigen Rapid Test N/A
Completed NCT04758299 - Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits N/A
Active, not recruiting NCT05365750 - COVID-19 Antibody and Reinfection Study
Recruiting NCT05139927 - Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers Phase 2
Withdrawn NCT04696601 - Rapid Screening for Olfactory Disorders in Covid-19 Infection N/A
Completed NCT04913116 - Generic Testing of Antigen Tests for COVID-19 in Denmark
Completed NCT04757298 - Optimization of a New Adaptive Intervention to Increase COVID-19 Testing N/A